The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways

J Biol Chem. 2010 Sep 24;285(39):29965-73. doi: 10.1074/jbc.M110.128694. Epub 2010 Jul 20.

Abstract

Elevated plasma free fatty acid (FFA) levels in obesity may play a pathogenic role in the development of insulin resistance. However, molecular mechanisms linking FFA to insulin resistance remain poorly understood. Oxidative stress acts as a link between FFA and hepatic insulin resistance. NADPH oxidase 3 (NOX3)-derived reactive oxygen species (ROS) may mediate the effect of TNF-α on hepatocytes, in particular the drop in cellular glycogen content. In the present study, we define the critical role of NOX3-derived ROS in insulin resistance in db/db mice and HepG2 cells treated with palmitate. The db/db mice displayed increased serum FFA levels, excess generation of ROS, and up-regulation of NOX3 expression, accompanied by increased lipid accumulation and impaired glycogen content in the liver. Similar results were obtained from palmitate-treated HepG2 cells. The exposure of palmitate elevated ROS production and NOX3 expression and, in turn, increased gluconeogenesis and reduced glycogen content in HepG2 cells. We found that palmitate induced hepatic insulin resistance through JNK and p38(MAPK) pathways, which are rescued by siRNA-mediated NOX3 reduction. In conclusion, our data demonstrate a critical role of NOX3-derived ROS in palmitate-induced insulin resistance in hepatocytes, indicating that NOX3 is the predominant source of palmitate-induced ROS generation and that NOX3-derived ROS may drive palmitate-induced hepatic insulin resistance through JNK and p38(MAPK) pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / genetics
  • Glycogen / genetics
  • Glycogen / metabolism
  • Hep G2 Cells
  • Hepatocytes / metabolism*
  • Humans
  • Insulin Resistance*
  • Liver / metabolism
  • MAP Kinase Kinase 4 / genetics
  • MAP Kinase Kinase 4 / metabolism*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / genetics
  • Membrane Proteins / biosynthesis*
  • Membrane Proteins / genetics
  • Mice
  • NADPH Oxidases / biosynthesis*
  • NADPH Oxidases / genetics
  • Obesity / genetics
  • Obesity / metabolism
  • Oxidative Stress / drug effects
  • Oxidative Stress / genetics
  • Palmitic Acid / metabolism
  • Palmitic Acid / pharmacology*
  • Reactive Oxygen Species / metabolism*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • p38 Mitogen-Activated Protein Kinases / genetics
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Membrane Proteins
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Palmitic Acid
  • Glycogen
  • NADPH Oxidases
  • Nox3 protein, human
  • Nox3 protein, mouse
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4